# Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

> **NCT04925375** · PHASE2 · RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 38 (estimated)

## Conditions studied

- Interstitial Lung Disease
- Common Variable Immunodeficiency

## Interventions

- **DRUG:** Abatacept
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04925375
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-14
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2025-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04925375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04925375, "Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04925375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*